FDA Report On US Formula Supply Doesn’t Stop Criticism From Congress, Former Food Policy Chief
Executive Summary
On same day agency published strategy for ensuring formula supply, House Oversight Committee subcommittee members made clear they’re not convinced FDA could prevent repeat of 2022 shortage. Recently resigned FDA food policy chief also has doubts.
You may also be interested in...
House Energy And Commerce Lists Infant Formula Crisis First In Stating FDA Oversight Priorities
Infant formula supply shortage affecting US since early 2022 is first among multiple FDA concerns Energy and Commerce GOP leadership stated in plan submitted to Oversight and Rules Committee, as required in a standing House rule.
In Food Programs Restructuring, US FDA Has Designs On Clear Priorities, Chain Of Command
Following reviews prompted largely by formula supply crisis, FDA will move Center for Food Safety and Applied Nutrition and commissioner’s Office of Food Programs and Response to Human Foods Program headed by deputy commissioner. Office of Regulatory Affairs' structure also changing “to support the FDA organization as a whole,” says Commissioner Califf.
Congress Boosts FDA Food Safety Budget Nearly $700M, Orders Reports On Formula Supply
Appropriators are “concerned by the fragility of the infant formula supply chain and the detrimental health impacts that can arise from shortage of these regulated products.” Their report published with FY2023 omnibus appropriations also asks for list of Russian firms with pending NDAs, including OTCs.